Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Histopathology|December 20, 2016
The role of phosphorylated signal transducer and activator of transcription 3 (pSTAT3) in peripheral nerve sheath tumoursGauri Panse, Cheuk H Leung, Davis R Ingram, et al.Chest|April 14, 2021
Breast and Lung Effusion Survival Score Models: Improving Survival Prediction in Patients With Malignant Pleural Effusion and MetastasisSofia Molina, Gabriela Martinez-Zayas, Paula V Sainz, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 16, 2023
Pathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant TherapyAnnikka Weissferdt, Cheuk H Leung, Heather Lin, et al.Histopathology|August 11, 2017
Clinicopathological analysis of ATRX, DAXX and NOTCH receptor expression in angiosarcomasGauri Panse, John Sa Chrisinger, Cheuk H Leung, et al.Clinical Lung Cancer|February 26, 2022
Clinical Effectiveness and Safety of Anti-PD-(L)1 Therapy Among Older Adults With Advanced Non-Small Cell Lung CancerMehmet Altan, Eric K Singhi, Michelle Worst, et al.The Journal of Thoracic and Cardiovascular Surgery|October 10, 2023
Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancerHope Feldman, Boris Sepesi, Cheuk H Leung, et al.The Journal of Thoracic and Cardiovascular Surgery|February 22, 2022
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non-small cell lung cancerBoris Sepesi, Nicolas Zhou, William N William, et al.Nature Communications|August 20, 2021
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancerTina Cascone, Annikka Weissferdt, Myrna C B Godoy, et al.Frontiers in Oncology|October 31, 2022
The immune landscape of undifferentiated pleomorphic sarcomaRossana Lazcano, Carmelia M Barreto, Ruth Salazar, et al.Journal for Immunotherapy of Cancer|October 24, 2024
Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancerNicolas Zhou, Cheuk H Leung, William N William, et al.Pageof 2